5[1]Chang CN, Skalski V, Hua Zhou J, et al. Biochemical pharmical of (+)-and-(-) 2', 3'-dideoxy-3'-thiacytidine as antihepatitis B Virus agents. J Boil Chem, 1992, 267:22414
6[2]Leung NWY, Lai CL, Chang TT, et al. Three year Lamivudine therapy in chronic HBV. J Hepatology, 1999, 30:59 (Abstract GS5/25)
7[3]Dienstag J, Schiff E, Wright T, et al. Lamivudine treatment one year in previously untreated US hepatitis B patients: hitologic improvement and hepatitis B e-antigen seroconversion. Gastroenterology, 1998, 114:10148 (Abstract)
8[4]Tassopoulos NC, Volpes R, Pastore G, et al. Efficacy of Lamivudine in patients with hepatitis Beantigen-negative/hepatitis B Virus DNA-Positive Chronic hepatitis B. Hepatology, 1999, 29:889
9[5]Heathcote J, Schalm SW, Cianaira J, et al. Lamivudine and Intron A combination treatment in patients with Chronic hepatitis B infection. J Hepatology, 1998, 28:43 (Abstract GS2/07)
10[6]SchiffE, Karayalcin S, Grimm I, et al. A placebo controlled study of lamivudine and interferon α-2b in patients with chronic hepatitis B Who previously failed interferon therapy. Hepatology, 1998, 28:388A (Abstract 901)
